Searchable abstracts of presentations at key conferences in endocrinology

ea0081p402 | Pituitary and Neuroendocrinology | ECE2022

Central pontine myelinolysis: Case report

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , Montalban Mendez Cristina , Moreno Tirado Antonio , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro

Introduction: Central pontine myelinolysis (CPM) is a rare and potentially life-threatening complication of a sudden rise in serum osmolality. Along with extrapontine myelinolysis, it is part of the osmotic demyelination syndrome (ODS). Known risk factors include severe hyponatremia, alcoholism, thiazide use, hypokalemia, and malnourishment.Case report: We report the case of a 31-year-old-male with history of alcohol and cannabis dependence, who had atte...

ea0081p751 | Thyroid | ECE2022

Postoperative thyroglobulin (Tg) as a predictor of long-term recurrence in differentiated thyroid carcinoma (DTC)

Utrilla Uriarte Nerea , Badiola Molinuevo Miren , Urquijo Mateos Virginia , Gonzalez Fernandez Pedro , Genolla Subirats Jose , Santamaria Sandi Javier

Introduction: To determine the risk of recurrence in DTC, different clinical factors have been used (presence of adenopathies, extrathyroid extension, histology\..). The objective was to examine whether the value of early postoperative Tg concentration may also predict long-term recurrence of DTC.Material and Methods: The study included 249 consecutive patients (78.3% women, mean age 50.72 ± 14.26 years) with DTC who were initially treated by total ...

ea0081ep16 | Adrenal and Cardiovascular Endocrinology | ECE2022

Optimization of familial hypercholesterolemia diagnosis through LDL cholesterol correction formula for lipoprotein(a) levels

Borque Rosana Urdaniz , Gimeno Sergio Roman , Galende Elena Perez , Fernandez Gema Gonzalez , Martin Borja Sanz , Orna Jose Antonio Gimeno

Introduction: For the clinical diagnosis of heterozygous familial hypercholesterolemia (HeFH) validated algorithms are used, with the Dutch Lipid Clinic Network (DLCN) Criteria being the most recommended in our environment. One of the items that scores for the system proposed by the DLCN is the value of LDL cholesterol. However, LDLc levels can be distorted by lipoprotein a (Lpa(a)) levels.Objective: To analyze the change in the validity of the DLCN crit...

ea0081ep31 | Adrenal and Cardiovascular Endocrinology | ECE2022

Spontaneous haemorrhage of an adrenal angiomyolipoma: case report

Lazaro Paloma Gonzalez , Benitez Maria Zhao Montero , Mendez Cristina Montalban , Torrecilla Pedro Jimenez , Meneses Amparo Lomas , Garcia Ines Gomez

Introduction: Angiomyolipomas are rare mesenchymal tumours arising from the perivascular epithelioid cells. They are benign endocrinologically inactive tumours with a histological structure consisting of variable amounts of adipose, thick-walled blood vessels and smooth muscle cells. Commonly, angiomyolipomas occur in the kidney with few extra renal case reports in adrenals.Case Report: We report the case of a 76-year-old-man with personal history of hyp...

ea0081ep366 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Characterization of a cohort of patients with type 1 diabetes during their unstructured transition to adult care

Braca Fernando , Novoa Yeray , Betancor Acosta Juan Carmelo , Fernandez-Trujillo Paula , Alvarado Martel Dacil , Gonzalez Martin Josu , Maria Wagner Ana

Background and aims: Transition of patients with type 1 diabetes (DM1) from pediatric to adult care is challenging and international guidelines recommend effective transition programs. The aim of this study is to describe our baseline situation, without a structured transition program, and to identify factors associated with worse glycemic outcome.Materials and Methods: This is an observational, retrospective study of patients with DM1, aged 14 or more o...

ea0050oc3.3 | Obesity, Diabetes Thyroid | SFEBES2017

The GLP-1R agonist exendin-4 reduces cerebrospinal fluid secretion and intracranial pressure

Botfield Hannah , Uldall Maria , Westgate Connar , Mitchell James , Hagen Snorre , Maria Gonzalez Ana , Hodson David , Jensen Rigmor , Sinclair Alexandra

Background: Current therapies for reducing raised intracranial pressure (ICP) in conditions such as idiopathic intracranial hypertension have limited efficacy and tolerability. As such, there is a pressing need to identify novel drugs. Glucagon-like peptide-1 receptor (GLP-1R) agonists are used to treat diabetes and promote weight loss but have also been shown to affect fluid homeostasis in the kidney. Here, we investigate whether exendin-4, a GLP-1R agonist, is able to modula...

ea0050oc3.3 | Obesity, Diabetes Thyroid | SFEBES2017

The GLP-1R agonist exendin-4 reduces cerebrospinal fluid secretion and intracranial pressure

Botfield Hannah , Uldall Maria , Westgate Connar , Mitchell James , Hagen Snorre , Maria Gonzalez Ana , Hodson David , Jensen Rigmor , Sinclair Alexandra

Background: Current therapies for reducing raised intracranial pressure (ICP) in conditions such as idiopathic intracranial hypertension have limited efficacy and tolerability. As such, there is a pressing need to identify novel drugs. Glucagon-like peptide-1 receptor (GLP-1R) agonists are used to treat diabetes and promote weight loss but have also been shown to affect fluid homeostasis in the kidney. Here, we investigate whether exendin-4, a GLP-1R agonist, is able to modula...

ea0090p363 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Bulimia Investigatory Test of Edinburgh (BITE) use in an endocrinology outpatient clinic

Alexandra Zapata Maldonado Gabriela , Gonzalez-Villa Maria , Luis Talledo Madrid Pedro , Ines Simbana Aragon Gabriela , Alcantara-Aragon Valeria

Objectives: To evaluate the prevalence of eating disorders (ED) at an Endocrinology outpatient clinic (EOC); with the use of Bulimia Investigatory Test of Edinburgh (BITE).Methods: Descriptive analysis of clinical characteristics and BITE scores from patients with suspicion of ED at a first appointment in an EOC with an average of 128 new patients/year. Data was collected from January-2021 to December-2022. The main suspicion criteria were: self-reported...

ea0090p617 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Case Report: Atypical presentation of central pontine myelinolysis in hyperglycemia

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , Moreno Tirado Antonio , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro , Gomez Garcia Ines

Central pontine myelinolysis (CPM) is a neurological disorder typically caused by rapid correction of severe chronic hyponatremia. Conditions causing a hyperosmolar state can also cause CPM, but it is rarely seen in diabetes. We report the case of a 33-year-old woman with personal history of Type 1 Diabetes since she was 9 years old with very poor metabolic control (A1hbC 15%) and microvascular complications, who attended the emergency department due to left hemicranial headac...

ea0090p207 | Thyroid | ECE2023

Thymic Hyperplasia and Graves’s Disease: A Non-Incidental Association

Pla Peris Begona , Abellan Galiana Pablo , Franch Salvador Sara , Gonzalez Boillos Margarita , Maravall Javier , Angel Merchante Alfaro Agustin

Introduction: Grave’s disease (GD) is an autoimmune disease characterized by the development of thyroid-stimulating hormone (TSH) receptor antibodies that have a stimulating effect on the thyroid gland. There is a rare but non-incidental and well-documented association between GD and thymic hyperplasia (TH). Nonetheless, this association is often underdiagnosed in routine clinical practice and the mechanisms behind this association have yet to be thoroughly elucidated. Th...